CS Diagnostics Corp.

OTCQB:CSDX USA Medical Devices
Market Cap
$104.12 Million
Market Cap Rank
#28293 Global
#9437 in USA
Share Price
$0.42
Change (1 day)
+6.79%
52-Week Range
$0.35 - $0.52
All Time High
$75.00
About

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The compa… Read more

CS Diagnostics Corp. (CSDX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.000x

Based on the latest financial reports, CS Diagnostics Corp. (CSDX) has a cash flow conversion efficiency ratio of 0.000x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-183.00) by net assets ($499.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

CS Diagnostics Corp. - Cash Flow Conversion Efficiency Trend (None–None)

This chart illustrates how CS Diagnostics Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

CS Diagnostics Corp. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CS Diagnostics Corp. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for CS Diagnostics Corp. (None–None)

The table below shows the annual cash flow conversion efficiency of CS Diagnostics Corp. from None to None.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
No yearly data available.